2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.
To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Abscess | D000038 | 13 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Hypertension, Renovascular | D006978 | 10 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Blood Loss, Surgical | D016063 | 6 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Saadeh M et al. | Reactive oxygen species stimulate insulin secretion in rat pancreatic islets: studies using mono-oleoyl-glycerol. | 2012 | PLoS ONE | pmid:22272304 |
| Panapisal V et al. | Formulation of microemulsion systems for dermal delivery of silymarin. | 2012 | AAPS PharmSciTech | pmid:22350738 |
| Chong JY et al. | High-throughput discovery of novel steric stabilizers for cubic lyotropic liquid crystal nanoparticle dispersions. | 2012 | Langmuir | pmid:22630595 |
| Kubicek J et al. | Controlled in meso phase crystallization--a method for the structural investigation of membrane proteins. | 2012 | PLoS ONE | pmid:22536388 |
| Moebus K et al. | Cubic phase-forming dry powders for controlled drug delivery on mucosal surfaces. | 2012 | J Control Release | pmid:21963767 |
| Onoue S et al. | Inhalable dry-emulsion formulation of cyclosporine A with improved anti-inflammatory effects in experimental asthma/COPD-model rats. | 2012 | Eur J Pharm Biopharm | pmid:22008148 |
| Cohen-Avrahami M et al. | Penetratin-induced transdermal delivery from H(II) mesophases of sodium diclofenac. | 2012 | J Control Release | pmid:22306174 |
| Lopes I et al. | Toxicity and genotoxicity of organic and inorganic nanoparticles to the bacteria Vibrio fischeri and Salmonella typhimurium. | 2012 | Ecotoxicology | pmid:22314390 |
| Garti N et al. | Lipolysis and structure controlled drug release from reversed hexagonal mesophase. | 2012 | Colloids Surf B Biointerfaces | pmid:22341515 |
| Pandit AA and Dash AK | Surface-modified solid lipid nanoparticulate formulation for ifosfamide: development and characterization. | 2011 | Nanomedicine (Lond) | pmid:22091968 |